DRUG · Unmapped registry intervention
Bimatoprost SR
Find medicine records ·
Find other trials using this name
Clinical trial
Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension
NCT02247804
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Active Comparator: Timolol 0.5%
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Sham: Applicator Without Needle
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Timolol Vehicle (placebo)
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEfficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Glaucoma, Open-Anglecandidate · MONDO: open-angle glaucoma
Interventions
Sponsors & collaborators
Allerganlead sponsor
Mapped research locations
San AntonioTexas, United States3BarcelonaSpain3WarsawPoland3HaifaIsrael3São PauloBrazil2Hong KongHong Kong2New YorkNew York, United States1HoustonTexas, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02247804 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.